NYSE:COO - Cooper Companies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$247.12 +1.28 (+0.52 %)
(As of 07/16/2018 08:07 AM ET)
Previous Close$245.84
Today's Range$244.73 - $248.21
52-Week Range$216.47 - $260.26
Volume276,377 shs
Average Volume459,704 shs
Market Capitalization$12.13 billion
P/E Ratio25.48
Dividend Yield0.02%
Cooper Companies logoThe Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies


Debt-to-Equity Ratio0.77
Current Ratio2.76
Quick Ratio1.67


Trailing P/E Ratio25.48
Forward P/E Ratio20.91
P/E Growth1.94

Sales & Book Value

Annual Sales$2.14 billion
Price / Sales5.67
Cash Flow$13.6757 per share
Price / Cash18.07
Book Value$64.88 per share
Price / Book3.81


EPS (Most Recent Fiscal Year)$9.70
Net Income$372.90 million
Net Margins5.58%
Return on Equity17.14%
Return on Assets9.68%


Outstanding Shares49,100,000
Market Cap$12,134.58

The Truth About Cryptocurrencies

Cooper Companies (NYSE:COO) Frequently Asked Questions

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies announced a dividend on Friday, July 13th. Investors of record on Monday, July 23rd will be given a dividend of $0.03 per share on Tuesday, August 7th. The ex-dividend date is Friday, July 20th. View Cooper Companies' Dividend History.

How will Cooper Companies' stock buyback program work?

Cooper Companies announced that its Board of Directors has authorized a share buyback program on Friday, April 7th 2017, which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 5.2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

How were Cooper Companies' earnings last quarter?

Cooper Companies Inc (NYSE:COO) announced its quarterly earnings results on Thursday, June, 7th. The medical device company reported $2.86 EPS for the quarter, topping the Zacks' consensus estimate of $2.84 by $0.02. The medical device company earned $631.30 million during the quarter, compared to analyst estimates of $627.49 million. Cooper Companies had a return on equity of 17.14% and a net margin of 5.58%. The firm's revenue was up 20.8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.50 earnings per share. View Cooper Companies' Earnings History.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 29th 2018. View Earnings Estimates for Cooper Companies.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY18 earnings guidance on Thursday, June, 7th. The company provided earnings per share (EPS) guidance of $11.70-11.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.79. The company issued revenue guidance of $2.52-2.55 billion, compared to the consensus revenue estimate of $2.53 billion.

What price target have analysts set for COO?

12 brokerages have issued 12 month target prices for Cooper Companies' shares. Their predictions range from $231.00 to $285.00. On average, they anticipate Cooper Companies' share price to reach $265.40 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price. View Analyst Ratings for Cooper Companies.

What is the consensus analysts' recommendation for Cooper Companies?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Cooper Companies' key competitors?

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the folowing people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 48)
  • Mr. Daniel G. McBride Esq., Chief Operating Officer, Exec. VP and Pres of CooperVision Inc (Age 54)
  • Mr. Agostino Ricupati, Chief Accounting Officer and Sr. VP of Fin. & Tax
  • Ms. Carol R. Kaufmann, Advisor (Age 69)
  • Mr. Brian Andrews, Sr. VP, CFO & Treasurer

Has Cooper Companies been receiving favorable news coverage?

Press coverage about COO stock has been trending positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cooper Companies earned a news sentiment score of 0.29 on Accern's scale. They also gave news articles about the medical device company an impact score of 46.66 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Handelsbanken Fonder AB (0.74%), Fisher Asset Management LLC (0.21%), NN Investment Partners Holdings N.V. (0.15%), James Hambro & Partners (0.09%) and Bank of Montreal Can (0.09%). Company insiders that own Cooper Companies stock include A Thomas Bender, Albert G White III, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss, Stanley Md Zinberg and William A Kozy. View Institutional Ownership Trends for Cooper Companies.

Which major investors are selling Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Fisher Asset Management LLC and Denali Advisors LLC. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Michael Kalkstein, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.

Which major investors are buying Cooper Companies stock?

COO stock was purchased by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Handelsbanken Fonder AB, James Hambro & Partners, Gateway Investment Advisers LLC, Contravisory Investment Management Inc., Bellecapital International Ltd., Fjarde AP Fonden Fourth Swedish National Pension Fund and IFM Investors Pty Ltd. View Insider Buying and Selling for Cooper Companies.

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $247.12.

How big of a company is Cooper Companies?

Cooper Companies has a market capitalization of $12.13 billion and generates $2.14 billion in revenue each year. The medical device company earns $372.90 million in net income (profit) each year or $9.70 on an earnings per share basis. Cooper Companies employs 11,800 workers across the globe.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

MarketBeat Community Rating for Cooper Companies (NYSE COO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  379 (Vote Outperform)
Underperform Votes:  334 (Vote Underperform)
Total Votes:  713
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.